In an episode of the LARVOL Onco Data Podcast, MONIKA LAMBA SAINI, our global translational pathology leader, joined Dr. Mark Gramling for a discussion of the clinical applications of artificial intelligence (#AI) in pathology and cancer research. Listen to the full episode here: https://lnkd.in/eY3-mgdG
Dr. MONIKA LAMBA SAINI joins Dr. Mark Gramling for a broader discussion beyond the usual trial-focused topics in this episode. This time, they explore the world of pathology and the latest technological advancements. Key points include: • The clinical applications of technology in pathology, where Dr. Monika shares insights from her experience in both molecular and digital pathology. • How AI is playing a role in diagnostic applications and how pathologists work and improve patient outcomes. Dr. Monika Lamba Saini, MBBS, MD, Ph.D., is the ‘Global Translational Pathology leader’ at ADC Therapeutics, where she is responsible for the scientific strategy, including the development and implementation of translational tissue-based biomarkers and using digital pathology as a tool to expedite the development pipeline. She previously served as the Director of Digital Pathology Innovation at Q2 Solutions, IQVIA, Edinburgh, where she provided stewardship of digital pathology from validation to implementation of the digital pathology systems, as well as providing pathology support for AI-based algorithms and digital image analyses. She is a pathologist-scientist with 20+ years of experience and proficiency in pathology. She comes with extensive experience in oncopathology, molecular pathology, and digital pathology with her PhD at the Université catholique de Louvain, Brussels, Belgium. She has been the principal investigator and sub-investigator of clinical trials for companion diagnostics in oncology with Cell Carta Belgium. Her experience spans across different countries and continents. She is the author and reviewer of many publications, including Lancet and Nature, and an invited speaker on international platforms. Professional interests include translational research, cancer biology, immunopathology, digital pathology, project design and management, medical writing/publications and public speaking. Tune in to hear how these developments are shaping the future of pathology and clinical diagnostics. #Oncology #Pathology #LARVOL #ClinicalData